Uric acid best predicts metabolically unhealthy obesity with increased cardiovascular risk in youth and adults

Obesity

Volumn 21, Issue 1, 2013, Pages E71-E77

  Mangge, Harald ^a   Zelzer, Sieglinde ^a   Puerstner, Peter ^a   Schnedl, Wolfgang J ^b   Reeves, Gloria ^c   Postolache, Teodor T ^c   Weghuber, Daniel ^d  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b General Practice for Internal Medicine   (Austria)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^d Paracelsus Medical School   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ALDOSTERONE; ALKALINE PHOSPHATASE; AMINOTRANSFERASE; C REACTIVE PROTEIN; CHOLINESTERASE; CREATININE; FIBRINOGEN; GAMMA GLUTAMYLTRANSFERASE; HYDROCORTISONE; INTERLEUKIN 6; LEPTIN; MALONALDEHYDE; OXIDIZED LOW DENSITY LIPOPROTEIN; RENIN; URIC ACID;

ADOLESCENT; ADULT; AREA UNDER THE CURVE; ARTERIAL WALL THICKNESS; ARTICLE; BODY FAT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; INTRAABDOMINAL FAT; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PREDICTION; PREVALENCE; RECEIVER OPERATING CHARACTERISTIC; URIC ACID BLOOD LEVEL;

EID: 84876271561     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.20061     Document Type: Article

References (31)

1. Stewart ST, Cutler DM, Rosen AB. Forecasting the effects of obesity and smoking on U.S. life expectancy. N Engl J Med 2009;361:2252-2260.
2. Arnlov J, Ingelsson E, Sundstrom J, et al. Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men. Circulation 2009;121:230-236.
3. Primeau V, Coderre L, Karelis AD, et al. Characterizing the profile of obese patients who are metabolically healthy. Int J Obes (Lond) 2010;35:971-981.
4. Pajunen P, Kotronen A, Korpi-Hyovalti E, et al. Metabolically healthy and unhealthy obesity phenotypes in the general population: the FIN-D2D Survey. BMC Public Health 2011;11:754.
5. Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120:1640-1645.
6. Calori G, Lattuada G, Piemonti L, et al. Prevalence, metabolic features, and prognosis of metabolically healthy obese Italian individuals: the Cremona study. Diabetes Care 2010;34:210-215.
7. Iwao S, Iwao N, Muller DC, et al. Does waist circumference add to the predictive power of the body mass index for coronary risk? Obes Res 2001;9:685-695. (Pubitemid 33603883)
8. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome-a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 2006;23:469-480.
9. Zimmet P, MM Alberti KG, Serrano Rios M. A new international diabetes federation worldwide definition of the metabolic syndrome: the rationale and the results. Rev Esp Cardiol 2005;58:1371-1376. (Pubitemid 43193350)
10. Moller R, Tafeit TE, Sudi TK, et al. Quantifying the 'appleness' or 'pearness' of the human body by subcutaneous adipose tissue distribution. Ann Hum Biol 2000; 27:47-55. (Pubitemid 30049456)
11. Kiechl S, Willeit J. The natural course of atherosclerosis. Part II: vascular remodeling. Bruneck Study Group. Arterioscler Thromb Vasc Biol 1999;19:1491-1498. (Pubitemid 29263019)
12. Pignoli P, Tremoli E, Poli A, et al. Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation 1986;74: 1399-1406. (Pubitemid 17189260)
13. Mangge H, Almer G, Haj-Yahya S, et al. Preatherosclerosis and adiponectin subfractions in obese adolescents. Obesity (Silver Spring) 2008;16:2578-2584.
14. Pilz S, Horejsi R, Moller R, et al. Early atherosclerosis in obese juveniles is associated with low serum levels of adiponectin. J Clin Endocrinol Metab 2005;90: 4792-4796. (Pubitemid 41159373)
15. Roob JM, Khoschsorur G, Tiran A, et al. Vitamin E attenuates oxidative stress induced by intravenous iron in patients on hemodialysis. J Am Soc Nephrol 2000; 11:539-549. (Pubitemid 30115084)
16. Zelzer S, Khoschsorur G, Stettin M, et al. Determination of myeloperoxidase in EDTA plasma: comparison of an enzyme-linked immunosorbent assay with a chemiluminescent automated immunoassay. Clin Chim Acta 2009;406:62-65.
17. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419. (Pubitemid 15018832)
18. Taksali SE, Caprio S, Dziura J, et al. High visceral and low abdominal subcutaneous fat stores in the obese adolescent: a determinant of an adverse metabolic phenotype. Diabetes 2008;57:367-371.
19. Preis SR, Massaro JM, Hoffmann U, et al. Neck circumference as a novel measure of cardiometabolic risk: the Framingham Heart study. J Clin Endocrinol Metab 2010;95:3701-3710.
20. Mangge H, Almer G, Haj-Yahya S, et al. Nuchal thickness of subcutaneous adipose tissue is tightly associated with an increased LMW/total adiponectin ratio in obese juveniles. Atherosclerosis 2009;203:277-283.
21. Tsouli SG, Liberopoulos EN, Mikhailidis DP, et al. Elevated serum uric acid levels in metabolic syndrome: an active component or an innocent bystander? Metabolism 2006 Oct; 55: 1293-1301. (Pubitemid 44354944)
22. Hongo M, Hidaka H, Sakaguchi S, et al. Association between serum uric acid levels and cardiometabolic risk factors among Japanese junior high school students. Circ J 2010;74:1570-1577.
23. Baker JF, Krishnan E, Chen L, et al. Serum uric acid and cardiovascular disease: recent developments, and where do they leave us? Am J Med 2005;118: 816-826. (Pubitemid 41097455)
24. Rao GN, Corson MA, Berk BC. Uric acid stimulates vascular smooth muscle cell proliferation by increasing platelet-derived growth factor A-chain expression. J Biol Chem 1991;266:8604-8608. (Pubitemid 21906552)
25. Corry DB, Eslami P, Yamamoto K, et al. Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular renin-angiotensin system. J Hypertens 2008;26:269-275.
26. Baldwin W, McRae S, Marek G, et al. Hyperuricemia as a mediator of the proinflammatory endocrine imbalance in the adipose tissue in a murine model of the metabolic syndrome. Diabetes 2011;60:1258-1269.
27. Alvarez-Lario B, Macarron-Vicente J. Is there anything good in uric acid? QJM 2011;104:1015-1024.
28. Kim TS, Pae CU, Yoon SJ, et al. Decreased plasma antioxidants in patients with Alzheimer's disease. Int J Geriatr Psychiatry 2006;21:344-348.
29. Irizarry MC, Raman R, Schwarzschild MA, et al. Plasma urate and progression of mild cognitive impairment. Neurodegener Dis 2009;6:23-28.
30. Kutzing MK, Firestein BL. Altered uric acid levels and disease states. J Pharmacol Exp Ther 2008;324:1-7. (Pubitemid 350294141)
31. Kloting N, Fasshauer M, Dietrich A, et al. Insulin-sensitive obesity. Am J Physiol Endocrinol Metab 2010;299:E506-E515.